Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurotec for improvement of tinnitus
IRCT2017042817413N23Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- May 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Neurotec in tinnitus, sponsored by Baqiyatallah University of Medical Sciences. Started May 2015; status: completed.
02
Drugs
Neurotec
03
Conditions
tinnitus
Beyond the preview
Go deeper on IRCT2017042817413N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017042817413N23.